Vaccine effectiveness against SARS-CoV-2 transmission to household contacts during dominance of Delta variant (B.1.617.2), August-September 2021, the Netherlands
View ORCID ProfileBrechje de Gier, Stijn Andeweg, Jantien A. Backer, RIVM COVID-19 surveillance and epidemiology team, Susan J.M. Hahné, Susan van den Hof, Hester E. de Melker, Mirjam J. Knol
doi: https://doi.org/10.1101/2021.10.14.21264959
Brechje de Gier
1Center for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands
Stijn Andeweg
1Center for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands
Jantien A. Backer
1Center for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands
1Center for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands
Susan J.M. Hahné
1Center for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands
Susan van den Hof
1Center for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands
Hester E. de Melker
1Center for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands
Mirjam J. Knol
1Center for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands
![Loading Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif)
- Supplementary[supplements/264959_file02.pdf]
Posted October 14, 2021.
Vaccine effectiveness against SARS-CoV-2 transmission to household contacts during dominance of Delta variant (B.1.617.2), August-September 2021, the Netherlands
Brechje de Gier, Stijn Andeweg, Jantien A. Backer, RIVM COVID-19 surveillance and epidemiology team, Susan J.M. Hahné, Susan van den Hof, Hester E. de Melker, Mirjam J. Knol
medRxiv 2021.10.14.21264959; doi: https://doi.org/10.1101/2021.10.14.21264959
Vaccine effectiveness against SARS-CoV-2 transmission to household contacts during dominance of Delta variant (B.1.617.2), August-September 2021, the Netherlands
Brechje de Gier, Stijn Andeweg, Jantien A. Backer, RIVM COVID-19 surveillance and epidemiology team, Susan J.M. Hahné, Susan van den Hof, Hester E. de Melker, Mirjam J. Knol
medRxiv 2021.10.14.21264959; doi: https://doi.org/10.1101/2021.10.14.21264959
Subject Area
Subject Areas
- Addiction Medicine (339)
- Allergy and Immunology (665)
- Anesthesia (179)
- Cardiovascular Medicine (2621)
- Dermatology (220)
- Emergency Medicine (396)
- Epidemiology (12161)
- Forensic Medicine (10)
- Gastroenterology (754)
- Genetic and Genomic Medicine (4053)
- Geriatric Medicine (383)
- Health Economics (674)
- Health Informatics (2616)
- Health Policy (996)
- Hematology (359)
- HIV/AIDS (839)
- Medical Education (397)
- Medical Ethics (109)
- Nephrology (429)
- Neurology (3823)
- Nursing (208)
- Nutrition (569)
- Oncology (2004)
- Ophthalmology (580)
- Orthopedics (238)
- Otolaryngology (303)
- Pain Medicine (250)
- Palliative Medicine (73)
- Pathology (470)
- Pediatrics (1106)
- Primary Care Research (445)
- Public and Global Health (6493)
- Radiology and Imaging (1384)
- Respiratory Medicine (868)
- Rheumatology (399)
- Sports Medicine (338)
- Surgery (440)
- Toxicology (52)
- Transplantation (185)
- Urology (165)